The FDA rounded out the month with the approval of remibrutinib (Rhapside; Novartis), a highly selective Bruton tyrosine kinase inhibitor (BTKi), for patients with chronic spontaneous urticaria (CSU) ...
The Miss USA 2025 pageant will be held in Reno on Friday. This year's contestants include an "American Ninja Warrior" ...
The drug, one of the few nonhormonal options for menopausal women, reduced hot flashes and night sweats, and appears to help ...
Dermatologist Dr. Nancy Samolitis breaks down how to treat dark spots, melasma, and sun damage on the 'Live + Well' podcast.
The federal Food and Drug Administration today approved a new menopause drug that reduces hot flashes and night sweats after ...
Final results from the pivotal CheckMate 238 trial showed adjuvant nivolumab continues to significantly improve RFS compared with ipilimumab for patients with advanced melanoma, according to data ...
Retinoids: Often referred to as “the gold standard” in anti-aging by dermatologists, retinoids like prescription-strength ...
Everyday Health on MSN
New FDA-Approved Eye Drops Could Replace Reading Glasses
Vizz (aceclidine ophthalmic solution) eye drops can improve near vision for up to 10 hours. Learn how the drops work and ...
Researchers assessed the quality of life measures of patients with thyroid eye disease treated with Veligrotug, a full antagonist humanized mAb to IGF-1R.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback